Literature DB >> 33131572

Resistance in Vancomycin-Resistant Enterococci.

William R Miller1, Barbara E Murray2, Louis B Rice3, Cesar A Arias4.   

Abstract

Serious infections owing to vancomycin-resistant enterococci have historically proven to be difficult clinical cases, requiring combination therapy and management of treatment-related toxicity. Despite the introduction of new antibiotics with activity against vancomycin-resistant enterococci to the therapeutic armamentarium, significant challenges remain. An understanding of the factors driving the emergence of resistance in vancomycin-resistant enterococci, the dynamics of gastrointestinal colonization and microbiota-mediated colonization resistance, and the mechanisms of resistance to the currently available therapeutics will permit clinicians to be better prepared to tackle these challenging hospital-associated pathogens.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Colonization resistance; Mechanisms of resistance; VRE; VRE colonization; Vancomycin resistant enterococcus

Mesh：

Substances：

Year:  2020        PMID： 33131572      PMCID： PMC7640809          DOI： 10.1016/j.idc.2020.08.004

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN： 0891-5520            Impact factor:   5.982


  140 in total

1.  Oritavancin disrupts membrane integrity of Staphylococcus aureus and vancomycin-resistant enterococci to effect rapid bacterial killing.

Authors:  Adam Belley; Geoffrey A McKay; Francis F Arhin; Ingrid Sarmiento; Sylvain Beaulieu; Ibthihal Fadhil; Thomas R Parr; Gregory Moeck
Journal:  Antimicrob Agents Chemother       Date:  2010-09-27       Impact factor: 5.191

2.  Rampant Parasexuality Evolves in a Hospital Pathogen during Antibiotic Selection.

Authors:  Kathryn Beabout; Troy G Hammerstrom; Tim T Wang; Minny Bhatty; Peter J Christie; Gerda Saxer; Yousif Shamoo
Journal:  Mol Biol Evol       Date:  2015-06-09       Impact factor: 16.240

3.  Detection of the phenicol-oxazolidinone-tetracycline resistance gene poxtA in Enterococcus faecium and Enterococcus faecalis of food-producing animal origin in China.

Authors:  Chang-Wei Lei; Zhuang-Zhuang Kang; Shun-Kang Wu; Yan-Peng Chen; Ling-Han Kong; Hong-Ning Wang
Journal:  J Antimicrob Chemother       Date:  2019-08-01       Impact factor: 5.790

4.  Differential Penicillin-Binding Protein 5 (PBP5) Levels in the Enterococcus faecium Clades with Different Levels of Ampicillin Resistance.

Authors:  Maria Camila Montealegre; Jung Hyeob Roh; Meredith Rae; Milya G Davlieva; Kavindra V Singh; Yousif Shamoo; Barbara E Murray
Journal:  Antimicrob Agents Chemother       Date:  2016-12-27       Impact factor: 5.191

Review 5.  New lipoglycopeptides: a comparative review of dalbavancin, oritavancin and telavancin.

Authors:  George G Zhanel; Divna Calic; Frank Schweizer; Sheryl Zelenitsky; Heather Adam; Philippe R S Lagacé-Wiens; Ethan Rubinstein; Alfred S Gin; Daryl J Hoban; James A Karlowsky
Journal:  Drugs       Date:  2010-05-07       Impact factor: 9.546

Review 6.  A Review of Combination Antimicrobial Therapy for Enterococcus faecalis Bloodstream Infections and Infective Endocarditis.

Authors:  Maya Beganovic; Megan K Luther; Louis B Rice; Cesar A Arias; Michael J Rybak; Kerry L LaPlante
Journal:  Clin Infect Dis       Date:  2018-07-02       Impact factor: 9.079

7.  Plasmid-mediated resistance to aminocyclitol antibiotics in group D streptococci.

Authors:  P Courvalin; C Carlier; E Collatz
Journal:  J Bacteriol       Date:  1980-08       Impact factor: 3.490

8.  Gastrointestinal Tract Colonization Dynamics by Different Enterococcus faecium Clades.

Authors:  Maria Camila Montealegre; Kavindra V Singh; Barbara E Murray
Journal:  J Infect Dis       Date:  2015-12-15       Impact factor: 5.226

9.  Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits.

Authors:  Katharina Brandl; George Plitas; Coralia N Mihu; Carles Ubeda; Ting Jia; Martin Fleisher; Bernd Schnabl; Ronald P DeMatteo; Eric G Pamer
Journal:  Nature       Date:  2008-08-24       Impact factor: 49.962

10.  Bacteriocin production augments niche competition by enterococci in the mammalian gastrointestinal tract.

Authors:  Sushma Kommineni; Daniel J Bretl; Vy Lam; Rajrupa Chakraborty; Michael Hayward; Pippa Simpson; Yumei Cao; Pavlos Bousounis; Christopher J Kristich; Nita H Salzman
Journal:  Nature       Date:  2015-10-19       Impact factor: 49.962
View more
  10 in total

1.  Descriptive Analysis of Circulating Antimicrobial Resistance Genes in Vancomycin-Resistant Enterococcus (VRE) during the COVID-19 Pandemic.

Authors:  Dan Alexandru Toc; Anca Livia Butiuc-Keul; Dumitrana Iordache; Alexandru Botan; Razvan Marian Mihaila; Carmen Anca Costache; Ioana Alina Colosi; Claudia Chiorean; Dan Stefan Neagoe; Liana Gheorghiu; Lia Monica Junie
Journal:  Biomedicines       Date:  2022-05-12

Review 2.  Regulation of Resistance in Vancomycin-Resistant Enterococci: The VanRS Two-Component System.

Authors:  Alexandra A Guffey; Patrick J Loll
Journal:  Microorganisms       Date:  2021-09-25

3.  Activity of Oritavancin against Gram-Positive Pathogens Causing Bloodstream Infections in the United States over 10 Years: Focus on Drug-Resistant Enterococcal Subsets (2010-2019).

Authors:  Cecilia G Carvalhaes; Helio S Sader; Jennifer M Streit; Mariana Castanheira; Rodrigo E Mendes
Journal:  Antimicrob Agents Chemother       Date:  2021-11-22       Impact factor: 5.191

4.  Rapid and Reproducible MALDI-TOF-Based Method for the Detection of Vancomycin-Resistant Enterococcus faecium Using Classifying Algorithms.

Authors:  Ana Candela; Manuel J Arroyo; Ángela Sánchez-Molleda; Gema Méndez; Lidia Quiroga; Adrián Ruiz; Emilia Cercenado; Mercedes Marín; Patricia Muñoz; Luis Mancera; David Rodríguez-Temporal; Belén Rodríguez-Sánchez
Journal:  Diagnostics (Basel)       Date:  2022-01-27

5.  Nosocomial Infections in Non-COVID-19 Pediatric Patients Prior to and During the Pandemic in a Pediatric Intensive Care Unit.

Authors:  Sevcan İpek; Ahmet Şahin; Sukru Gungor; Sadık Yurttutan; Ufuk U Güllü; Sermin Inal; Şeyma Demiray
Journal:  Cureus       Date:  2022-01-20

6.  Sentinel Surveillance Reveals Emerging Daptomycin-Resistant ST736 Enterococcus faecium and Multiple Mechanisms of Linezolid Resistance in Enterococci in the United States.

Authors:  Amy S Gargis; Lori M Spicer; Alyssa G Kent; Wenming Zhu; Davina Campbell; Gillian McAllister; Thomas O Ewing; Valerie Albrecht; Valerie A Stevens; Mili Sheth; Jasmine Padilla; Dhwani Batra; J Kristie Johnson; Alison Laufer Halpin; J Kamile Rasheed; Christopher A Elkins; Maria Karlsson; Joseph D Lutgring
Journal:  Front Microbiol       Date:  2022-02-01       Impact factor: 5.640

7.  Antimicrobial-Resistant Enterococcus spp. in Wild Avifauna from Central Italy.

Authors:  Giulia Cagnoli; Fabrizio Bertelloni; Paolo Interrante; Renato Ceccherelli; Margherita Marzoni; Valentina Virginia Ebani
Journal:  Antibiotics (Basel)       Date:  2022-06-24

8.  Heteroaryl-Ethylenes as New Effective Agents for High Priority Gram-Positive and Gram-Negative Bacterial Clinical Isolates.

Authors:  Dalida Angela Bivona; Alessia Mirabile; Carmelo Bonomo; Paolo Giuseppe Bonacci; Stefano Stracquadanio; Andrea Marino; Floriana Campanile; Carmela Bonaccorso; Cosimo Gianluca Fortuna; Stefania Stefani; Nicolò Musso; Dafne Bongiorno
Journal:  Antibiotics (Basel)       Date:  2022-06-03

9.  In vitro Antimicrobial Activity of Fosfomycin, Rifampin, Vancomycin, Daptomycin Alone and in Combination Against Vancomycin-Resistant Enterococci.

Authors:  Jiepeng Tong; Yiheng Jiang; Hao Xu; Xuehang Jin; Li Zhang; Shuaibing Ying; Wei Yu; Yunqing Qiu
Journal:  Drug Des Devel Ther       Date:  2021-07-12       Impact factor: 4.162

10.  Effect of Vancomycin on Cytoplasmic Peptidoglycan Intermediates and van Operon mRNA Levels in VanA-Type Vancomycin-Resistant Enterococcus faecium.

Authors:  Shivani Gargvanshi; Harika Vemula; William G Gutheil
Journal:  J Bacteriol       Date:  2021-07-22       Impact factor: 3.490
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.